Boston CEO
November 2-3, 2026
Mandarin Oriental Hotel, Boston
Join Longwood Healthcare Leaders this fall as top BioPharma executives convene at the Mandarin Oriental, Boston for off-the-record discussions and top tier networking with BioPharma CEOs, heads of research and development, life science investors, and leading academics.
Highlights
Boston CEO is co-hosted with leaders in the industry. See testimonials and highlights from speakers and attendees including MA Governor Maura Healey, Boston Mayor Michelle Wu, George Yancopoulos (CSO, Regeneron), Fiona Marshall (President, NIBR), Sally Kornbluth (President, MIT), Robert Plenge (Chief Research Officer, BMS), among others.
Boston CEO Co-Hosts
Boston CEO is co-hosted alongside leaders in the industry.
2025 Featured Speakers
Celebrated Academics
World-Class BioPharma CEOs
Renowned Researchers
Biotech Luminaries
Top Strategy Executives
Key Current & Former Government Officials
Blue-Chip Investors
Venue
Longwood Healthcare Leaders Boston CEO
is held at the Mandarin Oriental, Boston
2nd Floor Ballroom
776 Boylston St, Boston, MA 02199
617-535 8888
2025 Agenda
Day 1
7:00 am
REGISTRATION & NETWORKING BREAKFAST
7:30 am
LONGWOOD FUND INTRODUCTION
Lizzie Ngo, Principal, Longwood Fund
8:00 am
R&D COLLABORATION
Uli Bialucha, CSO, Xilio Therapeutics
Ben Ebert, CEO, Dana-Farber Cancer Institute
Oscar Izeboud, CEO, Scenic Biotech
Nancy Whiting, CEO, Recludix
Moderator: Markus Haeberlein, EVP, Discovery Science, Parabilis
8:30 am
TRANSLATING SCIENCE INTO MEDICINE
Giulio Draetta, CSO, MD Anderson
Susan Hockfield, President Emerita, MIT
Greg Petsko, Professor, Neurology, Harvard Medical School
Greg Verdine, Executive Chair, VidaVinci
Moderator: Gaurav Shah, CEO, Rocket Pharmaceuticals
9:00 am
CONGRESSIONAL KEYNOTE
Jake Auchincloss, Congressman, Massachusetts
Moderator: Christoph Westphal, General Partner, Longwood Fund
9:20 am
FIRESIDE CHAT
Marc Casper, CEO, Thermo Fisher Scientific
Levi Garraway, CMO, Roche Genentech
Moderator: Christoph Westphal, General Partner, Longwood Fund
9:40 am
NETWORKING BREAK
10:10 am
ADVANCES IN CLINICAL TRIALS
Cicely Fadel, Senior Program Officer, Gates Foundation
Catherine Sabatos-Peyton, CEO, Larkspur Biosciences
Sarah Sheikh, Head, Global Development & Head, Neuroscience TA, Takeda
Alexis Wallace, CEO, Thrombolytic Science
Moderator: Jim Anthony, CCO & President, Parexel Biotech
10:40 am
POSITIONING FOR COMMERCIAL SUCCESS
Sharon Benzeno, CCO, Adaptive Biotechnologies
Keting Chu, CEO, Bluejay Therapeutics
Tolga Tanguler, CCO, Alnylam
Scott Weintraub, SVP, US Business, Alexion, AstraZeneca Rare Disease
Moderator: Robert Stanislaro, Senior Managing Director, FTI Consulting
11:10 am
GUBERNATORIAL KEYNOTE
Maura Healey, Governor, Massachusetts
Moderator: Christoph Westphal, General Partner, Longwood Fund
11:30 am
EXPANDING PLATFORM POTENTIAL
Margo Georgiadis, CEO, Montai Therapeutics
Mathai Mammen, CEO, Parabilis
Raj Prasad, CFO, CRISPR Therapeutics
Joanne Smith-Farrell, CEO, Be Bio
Moderator: Mat Pletcher, CSO, Weaver
12:00 pm
NETWORKING LUNCHEON
1:00 pm
NAVIGATING THE REGULATORY LANDSCAPE
Peter Hutt, General Counsel (former), FDA
Thomas Lönngren, Executive Director (former), EMA
Lori Lyons-Williams, CEO, Abdera Therapeutics
Amanda Wagner, CEO, Immunitas Therapeutics
Moderator: Lisa Ricciardi, CEO, Cognition Therapeutics
1:30 pm
NAVIGATING PARTNERSHIPS ACROSS BORDERS
Mark Barrett, CBO, Madrigal Pharmaceuticals
Carla Lema Tomé, Executive Director, BD, Otsuka
Philippe Lopes-Fernandes, CBO, Ipsen
Atul Saran, CEO, IntegerBio
Moderator: Zhen Su, CEO, Marengo Therapeutics
2:00 pm
MANAGING THE RUNWAY
Brant Binder, CEO, Bonito Biosciences
David Hung, CEO, Nuvation Bio
Rachel Humphrey, CEO, Normunity
Daphne Karydas, President & CFO, Flare Therapeutics
Moderator: Brian McVeigh, CEO, Code Bio
2:30 pm
DRIVING PRODUCTIVITY IN R&D
Pedro Lichtinger, CEO, Starton Therapeutics
Morten Sogaard, SVP, Astellas Innovation Lab
Lara Sullivan, CEO, Pyxis Oncology
Quin Wills, CEO, Ochre Bio
Moderator: Sekhar Naik, CEO, MResult
3:00 pm
NETWORKING BREAK
3:20 pm
FIRESIDE CHAT
Bob Langer, Koch Institute Professor, MIT; Co-Founder, Moderna
Tim Springer, Latham Family Professor, Harvard; Co-Founder, Moderna
Moderator: Christoph Westphal, General Partner, Longwood Fund
3:40 pm
ENSURING HEALTH EQUITY AND PATIENT ACCESS
Julian Adams, CEO, Stand Up To Cancer
Geoffrey Chaiken, CEO, BlinkRx
John Glasspool, CEO, VarmX
Devan Shah, CEO, RNAV8 Bio
Moderator: Lizzie Ngo, Principal, Longwood Fund
4:10 pm
RNAi REVOLUTION: THE ALNYLAM STORY
Pushkal Garg, Chief R&D Officer, Alnylam
Phil Sharp, Koch Institute Professor, MIT; Scientific Co-Founder Biogen/Alnylam
Moderator: Christoph Westphal, General Partner, Longwood Fund
4:30 pm
INVESTOR OUTLOOK
Jessica Chutter, Managing Director, Vice Chair, Biotechnology Investment Banking, Morgan Stanley
Mike Ehlers, Entrepreneur Partner, MPM BioImpact
Jason Fuller, Partner, Deerfield
Mike Magliochetti, Operating Partner, Riverside Partners
Moderator: Vikas Goyal, Partner, Longwood Fund
Day 2
7:00 am
REGISTRATION & NETWORKING BREAKFAST
7:30 am
LONGWOOD FUND INTRODUCTION
Vikas Goyal, Partner, Longwood Fund
8:00 am
BIOPHARMA PIPELINE SOURCING
Charlotte Allerton, SVP, Head, Discovery & Early Development, Pfizer
Robert Baloh, Global Head, Neuroscience, Novartis Biomedical Research
Najat Khan, Chief R&D Officer & CCO, Recursion
Stephen Pitt, Global Head, Search, R&D, CSL
Moderator: Lucy Liu, Principal, Longwood Fund
8:30 am
PATIENT-CENTRIC DEVELOPMENT
Asa Abeliovich, CEO, Leal Therapeutics
Paul Bolno, CEO, Wave Life Sciences
Al Gianchetti, CEO, XyloCor
Maureen Hillenmeyer, CEO, Hexagon Bio
Moderator: Jim Scibetta, CEO, VectorY Therapeutics
9:00 am
DEVELOPING AN EFFECTIVE BOARD
David Donabedian, Founding CEO, Newleos Therapeutics; Executive Partner, Longwood Fund
Frank Haluska, CEO, Kestrel Therapeutics
Chris Loose, CEO, Progentos Therapeutics
Becca Senter, CSO, Axial Therapeutics
Moderator: Harvey Berger, CEO, Arena BioWorks
9:30 am
CROSSROADS OF SCIENCE AND POLICY: SUSTAINING THE ENGINE OF INNOVATION
Anna Greka, Founder & Chair, Broad L2C Accelerator
Anne Klibanski, CEO, Mass General Brigham
Sally Kornbluth, President, MIT
Kiame Mahaniah, Secretary, Health & Human Services, Massachusetts
Moderator: Meg Alexander, President & COO, Ovid Therapeutics
10:00 am
NETWORKING BREAK
10:20 am
ACCELERATING DRUG DISCOVERY
Joe Bolen, CEO, Orna Therapeutics
Marion Dorsch, CSO, Atavistik Bio
Greg Tietjen, CEO, Revalia Bio
Skip Virgin, Distinguished Fellow, AI Drug Discovery & Development, Gates Foundation
Moderator: John Lepore, CEO, ProFound Therapeutics
10:50 am
ADVANCING LATE-STAGE ASSETS
Jon Cohen, Head, Life Sciences, ServiceNow
Mike Exton, CEO, Lexicon Pharmaceuticals
Helen Sabzevari, CEO, Precigen
Milton Werner, CEO, ABLi Therapeutics
Moderator: Richard Paulson, CEO, Karyopharm
11:20 am
FIRESIDE CHAT
George Daley, Dean, Harvard Medical School
Miguel Fernández Alcalde, President, EMD Serono
Moderator: Christoph Westphal, General Partner, Longwood Fund
11:40 am
TARGETED LICENSING & ACQUSITIONS
Susan Hill, CEO, Mestag Therapeutics
Sekar Kathiresan, CEO, Verve Therapeutics
Stu Mackey, Global Head, BD, Daiichi Sankyo
Michael McCully, President & COO, Syndeio Biosciences
Moderator: Tim Ehrlich, Partner, Gunderson Dettmer
12:10 pm
NETWORKING LUNCHEON
1:10 pm
FIRESIDE CHAT
Dave Moore, EVP, US Operations & President Novo Nordisk, Inc.
Tarek Rabah, CEO, Otsuka North America
Priya Singhal, EVP, Head, Development, Biogen
Moderator: Peyton Howell, CEO, Parexel
1:30 pm
ECOSYSTEM OF EXTERNAL INNOVATION
Amira Barkal, Founding CEO, Pheast Therapeutics
Brian Foard, EVP, Global Specialty Care, Sanofi
Rick Lundberg, CEO, Eikonizo Therapeutics
Moderator: Maria Fardis, CEO, Lassen Therapeutics
2:00 pm
ACCELERATING DRUG DEVELOPMENT
Lotte Bjerre Knudsen, Chief Scientific Advisor, Novo Nordisk
Marianne De Backer, CEO, Vir Bio
Bari Kowal, SVP, Head, Development Operations & Portfolio Management, Regeneron
Phil Vickers, CEO, Solu Therapeutics
Moderator: Yiannis Kiachopoulos, CEO, Causaly
2:30 pm
ADAPTING TO BUSINESS OPPORTUNITIES IN ASIA
Stewart Geary, Global Safety Officer, Eisai
Brian Goodman, Managing Director, Vida Ventures
Pam Stetkiewicz, CEO, Lybora
Neil Warma, CEO, ProMIS Neurosciences
Moderator: Rebecca Frey, Venture Partner, RTW Investments
2:50 pm
NETWORKING BREAK
3:20 pm
ENSURING GLOBAL ACCESS
Rachid Izzar, EVP, Global Product Strategy & Commercialization, Biogen
Stephanie Oestrich, Managing Director, Myeloma Investment Fund
Ram Palanki, CCO, REGENXBIO
David Setboun, COO, Alkeus Pharmaceuticals
Moderator: Vikram Karnani, CEO, Collegium Pharmaceutical
3:50 pm
DRIVING SOCIAL IMPACT ACROSS THE LIFE SCIENCES
Rob Perez, Founder & Chair, Life Science Cares
Chad Smith, CEO, Boston Symphony Orchestra
Moderator: Christoph Westphal, General Partner, Longwood Fund
4:10 pm
THE EVOLVING DEAL-MAKING LANDSCAPE
Janice Chen, CTO, Mammoth Biosciences
Vijay Iyengar, EVP, Global Medical Affairs, Product & Partnership Strategy, Incyte
Amanda Kay, Senior Partner & CBDO, Flagship Pioneering
Dan Omstead, CEO, Tekla Capital Management
Moderator: Kyle Lefkoff, General Partner, Boulder Ventures
4:40 pm
EVALUATING INVESTMENT RISK
Peter Bisgaard, Managing Director, Pivotal Life Science
Ansbert Gadicke, Managing Partner, MPM BioImpact
Naveed Siddiqi, Senior Partner, Venture Investments, Novo Holdings
Moderator: Annie Vemu, Senior Associate, Longwood Fund
5:10 pm
COCKTAIL RECEPTION
Speaking Faculty
